Wasatch Advisors LP Acquires 932,598 Shares of Certara, Inc. (NASDAQ:CERT)

Wasatch Advisors LP lifted its holdings in shares of Certara, Inc. (NASDAQ:CERT) by 23.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,924,845 shares of the company’s stock after purchasing an additional 932,598 shares during the quarter. Wasatch Advisors LP owned 3.07% of Certara worth $88,056,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in CERT. First Hawaiian Bank acquired a new stake in shares of Certara during the 1st quarter worth approximately $618,000. Mubadala Investment Co PJSC acquired a new position in Certara during the fourth quarter valued at approximately $169,135,000. Pineridge Advisors LLC acquired a new position in Certara during the fourth quarter valued at approximately $28,000. Comerica Bank raised its position in Certara by 1.7% during the fourth quarter. Comerica Bank now owns 55,469 shares of the company’s stock valued at $976,000 after purchasing an additional 929 shares in the last quarter. Finally, Scout Investments Inc. raised its position in Certara by 18.9% during the fourth quarter. Scout Investments Inc. now owns 368,790 shares of the company’s stock valued at $6,487,000 after purchasing an additional 58,746 shares in the last quarter. 73.96% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CERT has been the subject of several research analyst reports. Barclays lowered their price objective on shares of Certara from $18.00 to $16.00 and set an “equal weight” rating for the company in a research report on Friday. JMP Securities started coverage on shares of Certara in a research report on Thursday, April 4th. They set a “market perform” rating for the company. Finally, KeyCorp raised shares of Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 target price on the stock in a research note on Wednesday, April 10th. Seven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $19.81.

Certara Trading Up 0.1 %

Shares of Certara stock traded up $0.02 during trading on Tuesday, hitting $13.66. The company’s stock had a trading volume of 404,332 shares, compared to its average volume of 565,879. The company has a debt-to-equity ratio of 0.27, a current ratio of 3.26 and a quick ratio of 3.26. Certara, Inc. has a 52 week low of $11.81 and a 52 week high of $19.87. The stock has a market cap of $2.20 billion, a price-to-earnings ratio of -35.02, a price-to-earnings-growth ratio of 4.65 and a beta of 1.53. The stock has a 50-day moving average price of $15.92 and a two-hundred day moving average price of $16.83.

Certara (NASDAQ:CERT) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.01). Certara had a positive return on equity of 4.08% and a negative net margin of 17.02%. The business had revenue of $96.65 million during the quarter, compared to the consensus estimate of $94.48 million. Equities research analysts anticipate that Certara, Inc. will post 0.29 EPS for the current fiscal year.

Certara Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.